162 related articles for article (PubMed ID: 23370361)
1. Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells.
Lee JS; Yoon IS; Lee MS; Cha EY; Thuong PT; Diep TT; Kim JR
Biol Pharm Bull; 2013; 36(2):316-25. PubMed ID: 23370361
[TBL] [Abstract][Full Text] [Related]
2. Kahweol inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells.
Oh SH; Hwang YP; Choi JH; Jin SW; Lee GH; Han EH; Chung YH; Chung YC; Jeong HG
Food Chem Toxicol; 2018 Nov; 121():326-335. PubMed ID: 30205135
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
Yeh CT; Wu CH; Yen GC
Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
[TBL] [Abstract][Full Text] [Related]
4. The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
Yan C; Wei H; Minjuan Z; Yan X; Jingyue Y; Wenchao L; Sheng H
PLoS One; 2014; 9(5):e97697. PubMed ID: 24866893
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
6. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
[TBL] [Abstract][Full Text] [Related]
7. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
Yousef BA; Guerram M; Hassan HM; Hamdi AM; Zhang LY; Jiang ZZ
Oncol Rep; 2016 Feb; 35(2):1091-100. PubMed ID: 26718323
[TBL] [Abstract][Full Text] [Related]
8. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells.
Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Song IS; Kim JR; Chang ES
Phytother Res; 2013 May; 27(5):713-20. PubMed ID: 22767439
[TBL] [Abstract][Full Text] [Related]
10. Platycodin D induces apoptosis in MCF-7 human breast cancer cells.
Yu JS; Kim AK
J Med Food; 2010 Apr; 13(2):298-305. PubMed ID: 20412017
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells.
Lee MS; Cha EY; Thuong PT; Kim JY; Ahn MS; Sul JY
Biol Pharm Bull; 2010; 33(6):931-7. PubMed ID: 20522955
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
Jin Q; Yuan LX; Boulbes D; Baek JM; Wang YN; Gomez-Cabello D; Hawke DH; Yeung SC; Lee MH; Hortobagyi GN; Hung MC; Esteva FJ
Breast Cancer Res; 2010; 12(6):R96. PubMed ID: 21080941
[TBL] [Abstract][Full Text] [Related]
13. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
14. Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Jang BH; Go H; Shin YC; Ko SG
Mol Med Rep; 2015 Aug; 12(2):2977-84. PubMed ID: 25936427
[TBL] [Abstract][Full Text] [Related]
15. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells.
Byun JY; Kim MJ; Eum DY; Yoon CH; Seo WD; Park KH; Hyun JW; Lee YS; Lee JS; Yoon MY; Lee SJ
Mol Pharmacol; 2009 Oct; 76(4):734-44. PubMed ID: 19574249
[TBL] [Abstract][Full Text] [Related]
17. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the antimetastatic and anticancer activities of morin in HER2‑overexpressing breast cancer SK‑BR‑3 cells.
Lee KS; Lee MG; Nam KS
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982761
[TBL] [Abstract][Full Text] [Related]
19. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells.
Do MT; Kim HG; Choi JH; Khanal T; Park BH; Tran TP; Jeong TC; Jeong HG
Food Chem; 2013 Dec; 141(3):2591-9. PubMed ID: 23870999
[TBL] [Abstract][Full Text] [Related]
20. Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation.
Chiang CT; Way TD; Tsai SJ; Lin JK
FEBS Lett; 2007 Dec; 581(30):5735-42. PubMed ID: 18022396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
